Doxorubicin (Sun Pharmaceutical)

N/A

Report date: 2026/01/26 13:50:19

Base Information

Drug NameDoxorubicin (Sun Pharmaceutical)
Drug Alias NameDoxorubicinSPARC-08-038
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Anthracycline antibiotics
Mechanisms of ActionTopoisomerase II inhibitorsDNA intercalatorsVirus DNA polymerase inhibitors
TargetsTopoisomerase IIDNAVirus DNA polymerase
Therapy Area/IndicationsOvarian NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSun Pharmaceutical Advanced Research Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSun Pharmaceutical Advanced Research Co Ltd
Active IndicationsN/A
Inactive IndicationsOvarian NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A